OmniAb, Inc. is a biotechnology company that specializes in the discovery and development of therapeutic antibodies
By leveraging its proprietary technologies and platforms, the company aims to generate a diverse array of high-quality antibodies for various therapeutic applications, focusing primarily on areas such as oncology, autoimmune diseases, and infectious diseases. OmniAb collaborates with other biotechnology and pharmaceutical companies to enhance drug discovery processes, ultimately seeking to advance innovative treatments that can address unmet medical needs.
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQTIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQIDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
The Dow Jones closed higher on Monday after recording losses last week. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Companies Reporting Before The Bell • Creative Realities (NASDAQCREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
